Home »
Academic Articles & Research Papers
Showing 8 of 48 academic articles
Demi Brownlie, Andreas von Kries, Giampiero Valenzano, Nicole Wild et al. • OncoImmunology
(2023)
Lung cancer is a leading cause of cancer-related death worldwide. Despite recent advances in tissue immunology, little is known about the spatial distribution of tissue-resident lymphocyte subsets in lung tumors. Using high-parameter flow c...
DOAJ
Open Access (DOAJ)
DOI: 10.1080/2162402X.2023.2233402
Mark W. D. Sweep, Mark W. D. Sweep, Martijn J. H. Tjan, Mark A. J. Gorris et al. • Frontiers in Immunology
(2023)
Immune checkpoint inhibitor therapy for cancer treatment can give rise to a variety of adverse events. Here we report a male patient with metastatic melanoma who experienced life-threatening colitis and duodenitis following treatment with i...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fimmu.2023.1212432
Toshihiro Uemura, Atsunari Kawashima, Kentaro Jingushi, Daisuke Motooka et al. • Scientific Reports
(2026)
Abstract Shotgun metagenomic sequencing provides more detailed microbial information than 16 S rRNA sequencing but requires higher cost and larger sample volumes. We evaluated whether shotgun metagenomic sequencing could detect bacterial DN...
DOAJ
Open Access (DOAJ)
DOI: 10.1038/s41598-026-59896-8
Angel Chao, Ren-Chin Wu, Chiao-Yun Lin, Ting-Chang Chang et al. • Biomedical Journal
(2023)
Small cell neuroendocrine carcinoma of the cervix (SCNECC) is an uncommon but aggressive uterine malignancy, the cause of which is generally associated with human papillomavirus (HPV) infection. A lack of clinical trials and evidence-based ...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.bj.2023.100633
Gu Y, Xu Z, Zhao J, Li H et al. • Frontiers in oncology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fonc.2026.1954751
PMC: PMC13732472
Leander van Eekelen, Joey Spronck, Monika Looijen-Salamon, Shoko Vos et al. • Scientific Reports
(2024)
Abstract Programmed death-ligand 1 (PD-L1) expression is currently used in the clinic to assess eligibility for immune-checkpoint inhibitors via the tumor proportion score (TPS), but its efficacy is limited by high interobserver variability...
DOAJ
Open Access (DOAJ)
DOI: 10.1038/s41598-024-57067-1
Fangmin Zhong, Fangyi Yao, Zihao Wang, Bo Huang et al. • npj Precision Oncology
(2025)
Abstract Acute myeloid leukemia (AML) remains challenging due to molecular heterogeneity and limited prognostic models integrating tumor microenvironment dynamics. While thrombocytopenia correlates with poor outcomes, the roles of platelet-...
DOAJ
Open Access (DOAJ)
DOI: 10.1038/s41698-025-01137-8
Chakraborty S, Corrales E, Godbole I, Madkhali N et al. • Genome medicine
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1186/s13073-026-01794-9
PMC: PMC13737523